Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Nov 22:19:6315-6327.
doi: 10.1016/j.csbj.2021.11.030. eCollection 2021.

M-MuLV reverse transcriptase: Selected properties and improved mutants

Affiliations
Review

M-MuLV reverse transcriptase: Selected properties and improved mutants

Igor P Oscorbin et al. Comput Struct Biotechnol J. .

Abstract

Reverse transcriptases (RTs) are enzymes synthesizing DNA using RNA as the template and serving as the standard tools in modern biotechnology and molecular diagnostics. To date, the most commonly used reverse transcriptase is the enzyme from Moloney murine leukemia virus, M-MuLV RT. Since its discovery, M-MuLV RT has become indispensable for modern RNA studies; the range of M-MuLV RT applications is vast, from scientific tasks to clinical testing of human pathogens. This review will give a brief description of the structure, thermal stability, processivity, and fidelity, focusing on improving M-MuLV RT for practical usage.

Keywords: Fusion proteins; M-MuLV RT; Random mutagenesis; Reverse transcriptase; Site-directed mutagenesis.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Figures

None
Graphical abstract
Fig. 1
Fig. 1
Schematic representation of M-MuLV RT structure (A) and functionally important amino acids residues (B).

Similar articles

Cited by

References

    1. Gross L. “Spontaneous” leukemia developing in C3H mice following inoculation in infancy, with AK-leukemic extracts, or AK-embrvos. Proc Soc Exp Biol Med. 1951;76:27–32. - PubMed
    1. Gross L. Filterable agent causing leukemia following inoculation into newborn. Tex Rep Biol Med. 1957;15 - PubMed
    1. Moloney J.B. Properties of a leukemia virus. Natl Cancer Inst Monogr. 1960;4:7–37. - PubMed
    1. Moloney J.B. Biological studies on a lymphoid-leukemia virus extracted from sarcoma 37. I. Origin and introductory investigations. J Natl Cancer Inst. 1960;24:933–951. - PubMed
    1. Murine R.A., Viruses L. Objects and Organisms. Adv Virol. 2011;2011:1–14. doi: 10.1155/2011/403419. - DOI - PMC - PubMed

LinkOut - more resources